Research location
Mennecy
France
Advertisement
Research activity in Mennecy
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Mennecy
8 linked trials · page 1 of 1SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesNCT05598684 · 2022-11-24 · 1 site observation
UNKNOWN
Evaluation of Target Organs Impairment on Patients Suffering From High Blood PressureNCT00925470 · 2009-06-01 · 1 site observation
COMPLETED
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-InhibitorNCT01557348 · 2009-06-01 · 1 site observation
COMPLETED
Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational StudyNCT00909038 · 2009-05-01 · 1 site observation
COMPLETED
Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)NCT00882128 · 2009-05-01 · 1 site observation
COMPLETED
National Survey on HypertensionNCT00804167 · 2008-12-01 · 1 site observation
COMPLETED
National Survey on Hypertension in Cardiologic Private PracticeNCT00695175 · 2008-02-01 · 1 site observation
COMPLETED
Cardiovascular Risk Assessment in Patients Treated With CaduetNCT00297973 · 2006-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.